Stay updated with breaking news from Steve heymsfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LSU Scientist Works with Amazon to Fight Obesity, Diabetes Using Smartphones and AI sciencex.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencex.com Daily Mail and Mail on Sunday newspapers.
Limitations of the study included the sample size of the participants and a gender imbalance across the groups, with more women randomized to bimagrumab and more men to the placebo. ....
These exciting results suggest that there may be a novel mechanism for achieving weight loss with a profound loss of body fat and an increase in lean mass, along with other metabolic benefits, said Steve Heymsfield, MD, FTOS, past president of The Obesity Society and corresponding author of the study. Heymsfield is professor and director of the Metabolism and Body Composition Laboratory at the Pennington Biomedical Research Center in Baton Rouge, La. What Is Bimagrumab? The study describes bimagrumab (BYM338; Novartis) as a human monoclonal antibody that binds to activin Type II receptors (ActRII) and in turn prevents specific molecular components from inhibiting skeletal muscle growth. Earlier studies involving skeletal muscle in mice, found that bimagrumab treatment had an effect on brown adipose tissue (BAT) differentiation and activity. ....
This medication shows promise for weight loss in patients with obesity, diabetes orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.